Company: LNAI
Filing Date: 2025-07-18
Form Type: PRE 14A
Source: 0001731122-25-000995
Chunk: 31

Company: Lunai Bioworks Inc.
Filing Date: 2025-07-18
Form: PRE 14A
Chunk 31
---
 in the future you would like to receive multiple copies of information or proxy statements, or annual reports,
or, if you are currently receiving multiple copies of these documents and would, in the future, like to receive only a single copy, please
so instruct Renovaro by writing to us at Renovaro Inc., 2080 Century Park East, Suite 906, Los Angeles, CA, Attention: Chief Financial
Officer.

<div align='center'>24

WHERE YOU CAN FIND MORE INFORMATION</div>

Renovaro is subject to the
information requirements of the Exchange Act. Accordingly, Renovaro files annual, quarterly and current reports, proxy statements as may
be required and other information with the SEC. You can review Renovaro’s filings by accessing the website maintained by the SEC
at http://www.sec.gov. The site contains reports, proxy and information statements and other information regarding issuers that file electronically
with the SEC.

In addition to the foregoing,
Renovaro maintains a website at https://www.renovarogroup.com. Information contained in this website is not part of, nor incorporated
by reference into, this proxy statement. Renovaro makes available free of charge, on or through its website, the annual, quarterly, and
current reports and any amendments to those reports filed or furnished by Renovaro pursuant to Section 13(a) of the Exchange Act
as soon as reasonably practicable after it electronically files such material with, or furnish it to, the SEC.

<div align='center'>25

INFORMATION INCORPORATED BY REFERENCE</div>

This proxy statement incorporates
by reference the Renovaro 2024 Form 10-K and the Renovaro Third Quarter 2025 Form 10-Q, which Renovaro has previously filed
with the SEC (other than, in each case, documents or information deemed to have been furnished and not filed in accordance with SEC rules).
They contain important information about Renovaro.

Those documents are considered
to be a part of this proxy statement, effective as of the date they are filed. In the event of conflicting information in those documents,
the information in the latest filed document should be considered correct.

If you would like to request
documents from Renovaro please send a request in writing or by telephone to Renovaro at the following address:

Renovaro Inc.

Investor Relations

2080 Century Park East, Suite 906

Los Angeles, CA 90067

Telephone: (305)